home / stock / orgo / orgo news


ORGO News and Press, Organogenesis Holdings Inc. From 05/10/23

Stock Information

Company Name: Organogenesis Holdings Inc.
Stock Symbol: ORGO
Market: NASDAQ
Website: organogenesis.com

Menu

ORGO ORGO Quote ORGO Short ORGO News ORGO Articles ORGO Message Board
Get ORGO Alerts

News, Short Squeeze, Breakout and More Instantly...

ORGO - Organogenesis Holdings Inc. (ORGO) Q1 2023 Earnings Call Transcript

2023-05-10 23:50:25 ET Organogenesis Holdings Inc. (ORGO) Q1 2023 Earnings Conference Call May 10, 2023 05:00 PM ET Company Participants Gary Gillheeney - President and CEO Dave Francisco - CFO Conference Call Participants Ryan Zimmerman - BTIG Pres...

ORGO - Organogenesis Holdings reports Q1 results, raises FY 2023 revenue guidance

2023-05-10 16:37:45 ET Organogenesis Holdings press release ( NASDAQ: ORGO ): Q1 GAAP EPS of -$0.02. Revenue of $107.6M (+10.8% Y/Y). Sees FY 2023 net revenue between $454 million and $466 million. ORGO had guided FY 2023 revenue of $450M and $462M. ...

ORGO - Organogenesis Holdings Inc. Reports First Quarter 2023 Financial Results

CANTON, Mass., May 10, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today rep...

ORGO - Organogenesis President and CEO, also named to Chair of the Board

2023-04-27 07:44:33 ET Organogenesis ( NASDAQ: ORGO ) Board of Directors has elected President and CEO Gary S. Gillheeney, Sr., as Chair of the Board, effective immediately. Gillheeney will continue in his role as President and CEO, which he has held since 2014. Mr. Gi...

ORGO - Organogenesis President and Chief Executive Officer Gary S. Gillheeney, Sr. Elected Chair of the Board of Directors

CANTON, Mass., April 27, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today ann...

ORGO - Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023

CANTON, Mass., April 10, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today ann...

ORGO - Organogenesis Applauds Findings from the Office of Inspector General

CANTON, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, applauds ...

ORGO - Why Shares of Unisys, Organogenesis, and Motorcar Parts of America Fell Today

2023-03-06 18:29:09 ET Shares of Unisys (NYSE: UIS) , Organogenesis Holdings (NASDAQ: ORGO) , and Motorcar Parts of America (NASDAQ: MPAA) fell today as all three stocks were removed from the S&P SmallCap 600 index as part of its quarterly rebalancing. Th...

ORGO - Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 Fair Isaac & Co. Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire NEW YORK , March 3, 2023 /PRNewswire/...

ORGO - Organogenesis' reports positive interim analysis of Phase 3 ReNu trial for knee pain

Organogenesis Holdings ( NASDAQ: ORGO ) has reported favorable outcome of the interim analysis of its Phase 3 trial of ReNu, a cryopreserved amniotic suspension allograft (ASA) for management of symptoms associated with knee osteoarthritis. The pre-specified interim analysis on 50...

Previous 10 Next 10